QuidelOrtho Corp (QDEL)
42.68
-1.20
(-2.73%)
USD |
NASDAQ |
May 08, 16:00
41.00
-1.68
(-3.94%)
After-Hours: 20:00
QuidelOrtho Enterprise Value: 5.100B for May 8, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 08, 2024 | 5.100B |
| May 07, 2024 | 5.181B |
| May 06, 2024 | 5.149B |
| May 03, 2024 | 5.088B |
| May 02, 2024 | 5.070B |
| May 01, 2024 | 4.900B |
| April 30, 2024 | 4.958B |
| April 29, 2024 | 4.878B |
| April 26, 2024 | 4.897B |
| April 25, 2024 | 4.901B |
| April 24, 2024 | 4.976B |
| April 23, 2024 | 4.948B |
| April 22, 2024 | 4.860B |
| April 19, 2024 | 4.862B |
| April 18, 2024 | 4.805B |
| April 17, 2024 | 4.835B |
| April 16, 2024 | 4.941B |
| April 15, 2024 | 5.018B |
| April 12, 2024 | 5.066B |
| April 11, 2024 | 5.120B |
| April 10, 2024 | 5.188B |
| April 09, 2024 | 5.231B |
| April 08, 2024 | 5.145B |
| April 05, 2024 | 5.102B |
| April 04, 2024 | 5.100B |
| Date | Value |
|---|---|
| April 03, 2024 | 5.090B |
| April 02, 2024 | 5.065B |
| April 01, 2024 | 5.389B |
| March 28, 2024 | 5.452B |
| March 27, 2024 | 5.473B |
| March 26, 2024 | 5.389B |
| March 25, 2024 | 5.421B |
| March 22, 2024 | 5.376B |
| March 21, 2024 | 5.410B |
| March 20, 2024 | 5.417B |
| March 19, 2024 | 5.481B |
| March 18, 2024 | 5.523B |
| March 15, 2024 | 5.483B |
| March 14, 2024 | 5.421B |
| March 13, 2024 | 5.407B |
| March 12, 2024 | 5.377B |
| March 11, 2024 | 5.375B |
| March 08, 2024 | 5.340B |
| March 07, 2024 | 5.237B |
| March 06, 2024 | 5.113B |
| March 05, 2024 | 5.118B |
| March 04, 2024 | 5.211B |
| March 01, 2024 | 5.291B |
| February 29, 2024 | 5.296B |
| February 28, 2024 | 5.262B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
2.198B
Minimum
May 23 2019
12.63B
Maximum
Aug 05 2020
5.958B
Average
5.777B
Median
Nov 19 2021
Enterprise Value Benchmarks
| Abbott Laboratories | 190.73B |
| Becton Dickinson & Co | 82.34B |
| Boston Scientific Corp | 115.44B |
| Tenon Medical Inc | 1.950M |
| Perspective Therapeutics Inc | 1.025B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 7.00M |
| Revenue (Quarterly) | 742.60M |
| Total Expenses (Quarterly) | 669.50M |
| EPS Diluted (Quarterly) | 0.10 |
| Gross Profit Margin (Quarterly) | 51.35% |
| Profit Margin (Quarterly) | 0.94% |
| Earnings Yield | -0.37% |
| Operating Earnings Yield | 8.84% |
| Normalized Earnings Yield | 2.017 |